Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment

Carcinoma,Non-Small-Cell Lung Clinical Trial

Official title:
An Open-Label, Non-Randomized, Single-Center Study to Preliminary Evaluation of Safety and Efficacy of Patients Who Participant in [14C] AC0010 Trail and Subsequent Receiving AC0010 Treatment

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate safety and efficacy of male Patients With Advanced NSCLC who participant in [14C] AC0010 ADME.

Clinical Trial Description

The purpose of this study is to evaluate safety and efficacy of male Patients With Advanced NSCLC who participant in [14C] AC0010 ADME (absorption, distribution, metabolism and excretion) trial and subsequent receiving AC0010 treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03053219
Study type	Interventional
Source	Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	November 2016
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03088540` - Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)	Phase 3
Completed	`NCT03044626` - Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC	Phase 2
Recruiting	`NCT02607592` - A Prospective Multi-center Phase III Randomized Controlled Trial	Phase 3